750
Participants
Start Date
July 30, 2018
Primary Completion Date
May 6, 2022
Study Completion Date
May 6, 2022
CHF 1535 100/6 µg pMDI plus Symbicort® Turbohaler® Placebo
Fixed combination of beclometasone dipropionate 100 µg plus formoterol fumarate 6 µg (BDP/FF)
Symbicort® Turbohaler® plus CHF 1535 pMDI Placebo
Fixed combination of 160 µg budesonide + 4.5 µg formoterol fumarate (BUD/FF)
Site 15613 - Beijing Friendship Hospital, Capital Medical University, Beijing
Site 15611 - Xuanwu Hospital Capital Medical University, Beijing
Site 15640 - Peking University Shougang Hospital, Beijing
Site 15626 - Peking University Third Hospital, Beijing
Site 15612 - Beijing Tong Ren Hospital, Capital Medical University, Beijing
Site 15648 - Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian
Site 15658 - Jilin Province People's Hospital, Changchun
Site 15643 - No.2 Hospital Affiliated to Jilin University, Changchun
Site 15628 - Shanghai Xuhui Center Hospital, Shanghai
Site 15601 - Huadong Hospital Afflilliated to Fudan University, Shanghai
Site 15631 - Shanghai Yangpu District Centre Hospital, Shanghai
Site 15610 - Tong Ren Hospital Shanghai Jiaotong University School of Medicine, Shanghai
Site 15606 - Shanghai Pulmonary Hospital, Shanghai
Site 15625 - Central Hospital of Shanghai Minhang District, Shanghai
Site 15657 - Zhong Da Hospital, Southeast University, Nanjing
Site 15627 - Nanjing Medical University Affiliated 2nd Hospital, Nanjing
Site 15632 - Xuzhou Central Hospital, Xuzhou
Site 15604 - Anhui Provincial Hospital, Hefei
Site 15635 - The Second Hospital of Anhui Medical Hospital, Hefei
Site 15621 - Wuxi People's Hospital, Wuxi
Site 15644 - Jinan Central Hospital, Jinan
Site 15609 - Tianjin First Center Hospital, Tianjin
Site 15633 - Tianjin Haihe Hospital, Tianjin
Site 15602 - Hangzhou First People's Hospital, Hangzhou
Site 15642 - Taizhou Hospital of Zhejiang Province, Taizhou
Site 15639 -The second Affiliated Hospital of Wenzhou Medical College, Wenzhou
Site 15659 - Jiangxi Provincial People's Hospital, Nanchang
Site 15636 - Fujian Province Hospital, Fuzhou
Site 15634 - Chongqing General Hospital, Chongqing
Site 15616 - Chongqing Red Cross Hospital, People's Hospital of Jiangbei District, Chongqing
Site 15622 - The Third Hospital of Changsha, Changsha
Site 15653 - Xiangtan Central Hospital, Xiangtan
Site 15647 - The Second hospital. University of South China, Hengyang
Site 15654 - Henan Provincial People's Hospital, Zhengzhou
Site 15617 - Henan Provincial Chest Hospital, Zhengzhou
Site 15619 - The Third Affiliated Hospital of Southern Medical University, Guangzhou
Site 15608 - The First Affiliated Hospital Sun Yat-sen University, Guangzhou
Site 15646 - The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
Site 15651 - The Second Xiangya Hospital of Central South University, Guangzhou
Site 15614 - Guangzhou Panyu central hospital, Guangzhou
Site 15630 - Dongguan People's Hospital, Dongguan
Site 15618 - Affiliated Hospital of Guangdong Medical University, Zhanjiang
Site 15607 - The First People's Hospital of Shunde, Foshan
Site 15656 - The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
Site 15637 - Affiliated Hospital of Zunyi Medical College, Zunyi
Site 15623 - Haikou People's Hospital, Haikou
Site 15645 - Hainan General Hospital, Haikou
Site 15605 - West China Hospital, Sichuan University, Chengdu
Site 15650 - The First Hospital of Lanzhou University, Lanzhou
Site 15629 - Shanghai East Hospital, Shanghai
Site 15603 - The Affiliated Hospital of Inner Mongolia Medical University, Hohhot
Site 15649 - The 1st Affiliated Hospital of Shanxi Medical University, Taiyuan
Site 15638 - Second Hospital of Shanxi Medical, Taiyuan
Chiesi Farmaceutici S.p.A.
INDUSTRY